TokenPost·
Bioventus Lowers 2026 Revenue Outlook to $590 Million-$595 Million
The company reaffirmed adjusted EPS guidance of $0.75 to $0.79 and expects mid-single-digit revenue growth in the fourth quarter.
More news
- TokenPostApple Shares Fall 4.5% in Premarket Trading Ahead of U.S. Open
- TokenPostAehr Raises Fiscal 2027 Revenue Outlook as Shares Rise After Hours
- TokenPostOKX Customer Bitcoin Balance Climbs 13,800 BTC in Reserve Snapshot
- CoinDeskNorth Korea denies role in $6.4 billion Binance hack after FBI points to TraderTraitor
- TokenPostBitcoin Wallet Opens $6.45 Million Short With $38.2 Million in Losses
- TokenPostBinance-Tracked Wallets Show $1.82 Billion in 24-Hour Net Inflows